Bridgeway Capital Management’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,615
| Closed | -$216K | – | 1473 |
|
|
2023
Q2 | $216K | Hold |
9,615
| – | – | 0.01% | 1121 |
|
|
2023
Q1 | $116K | Hold |
9,615
| – | – | ﹤0.01% | 1207 |
|
|
2022
Q4 | $43.8K | Sell |
9,615
-1,923
| -17% | -$8.75K | ﹤0.01% | 1308 |
|
|
2022
Q3 | $76K | Hold |
11,538
| – | – | ﹤0.01% | 1317 |
|
|
2022
Q2 | $125K | Sell |
11,538
-3,847
| -25% | -$41.7K | ﹤0.01% | 1188 |
|
|
2022
Q1 | $294K | Hold |
15,385
| – | – | 0.01% | 1088 |
|
|
2021
Q4 | $552K | Buy |
+15,385
| New | +$552K | 0.01% | 954 |
|